Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495703 | PMC |
| http://dx.doi.org/10.1177/1941874420923539 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Management of Renal Angiomyolipomas in Tuberous Sclerosis: A Case Series.
Vasc Specialist Int
December 2024
Department of Obstetrics and Gynecology, JSS Academy of Higher Education and Research, Mysuru, India.
Renal angiomyolipomas, benign tumors composed of blood vessels, adipose tissue, and smooth muscle, affect approximately 70% to 80% of patients with tuberous sclerosis. Angiomyolipomas smaller than 4 cm are usually asymptomatic, whereas larger ones can cause lumbar pain, anemia, and hematuria. Contrary to its sporadic counterparts, tuberous sclerosis-associated angiomyolipomas often present at a young age, are multicentric and large, and carry a higher risk of life-threatening hemorrhage.
View Article and Find Full Text PDFAn Intraoperative Ultrasound Evaluation of Axillary Lymph Nodes: Cassandra Predictive Models in Patients with Breast Cancer-A Multicentric Study.
Medicina (Kaunas)
November 2024
Department of Advanced Medical and Surgical Sciences, Division of General, Oncological, Mini-Invasive and Obesity Surgery-University of Study of Campania "Luigi Vanvitelli", 80136 Naples, Italy.
Axillary lymph node (ALN) staging is crucial for the management of invasive breast cancer (BC). Although various radiological investigations are available, ultrasound (US) is the preferred tool for evaluating ALNs. Despite its immediacy, widespread use, and good predictive value, US is limited by intra- and inter-operator variability.
View Article and Find Full Text PDFPediatric Solitary Epithelioid Histiocytoma of the Face.
J Craniofac Surg
November 2024
Department of Plastic and Reconstructive Surgery, Medical College of Wisconsin.
Background: Solitary epithelioid histiocytoma, also known as reticulohistiocytoma, is a rare benign histiocytic proliferation with an unreported incidence that commonly presents as a superficial nodule involving the trunk and extremities of adults. Pathology shows dermal histiocytic infiltration composed of large, eosinophilic histiocytes with "glassy" cytoplasm and oncocytic macrophages. When presenting as part of a systemic disorder, it is called multicentric reticulohistiocytosis, a rare and more aggressive condition characterized by multiple skin and mucosal lesions and arthritis.
View Article and Find Full Text PDFCastleman's Disease Presenting as an Unusual Pelvic Retroperitoneal Mass.
Cureus
October 2024
General Surgery, Shri B. M. Patil Medical College Hospital and Research Centre, BLDE (Deemed to be University), Vijayapura, IND.
Castleman's disease (CD) is characterised by benign lymphoepithelial proliferation and is a peculiar form of angiofollicular lymph node hyperplasia rather than a neoplasm or a hamartoma. CD is broadly classified as unicentric CD (UCD) and multicentric CD. In the unicentric variant, patients have localised disease affecting only a single lymph node or a group of adjacent nodes in a single region, which clinically presents as an enlarging mass without any other significant symptoms.
View Article and Find Full Text PDFCastleman disease mimicking accessory spleen on imaging: A case report.
Radiol Case Rep
January 2025
Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.
Castleman disease (CD) is a nonclonal lymphoproliferative disorder that causes non-neoplastic lymph node enlargement. With an incidence of approximately 21-25 cases per million, CD presents variably, often mimicking both benign and malignant conditions across various body regions. Clinically, it ranges from asymptomatic lymph node enlargement in Unicentric Castleman's Disease (UCD) to aggressive, multicentric presentations affecting multiple organs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!